Epidermal growth factor receptor (EGFR) monoclonal antibody inhibitors are used to treat metastatic colorectal cancers. Cetuximab, an EGFR inhibitor drug, targets specific molecular pathways and does not cause the severe systemic side effects seen in cytotoxic chemotherapy. Herein, we presented a case who developed acneiform eruptions during cetuximab treatment.
CETUXIMAB ACNEIFORM ERUPTION metastatic colorectal cancer K-ras
Birincil Dil | İngilizce |
---|---|
Konular | İç Hastalıkları |
Bölüm | Case Reports |
Yazarlar | |
Yayımlanma Tarihi | 1 Nisan 2022 |
Gönderilme Tarihi | 10 Şubat 2022 |
Kabul Tarihi | 9 Mart 2022 |
Yayımlandığı Sayı | Yıl 2022 Cilt: 4 - Supplement 1 |